FR2980702B1 - COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE - Google Patents

COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE

Info

Publication number
FR2980702B1
FR2980702B1 FR1158748A FR1158748A FR2980702B1 FR 2980702 B1 FR2980702 B1 FR 2980702B1 FR 1158748 A FR1158748 A FR 1158748A FR 1158748 A FR1158748 A FR 1158748A FR 2980702 B1 FR2980702 B1 FR 2980702B1
Authority
FR
France
Prior art keywords
alkyl
optionally
optionally substituted
amino
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1158748A
Other languages
French (fr)
Other versions
FR2980702A1 (en
Inventor
Herve David
Gwenaelle Jegou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1158748A priority Critical patent/FR2980702B1/en
Priority to PCT/EP2012/069362 priority patent/WO2013045702A2/en
Publication of FR2980702A1 publication Critical patent/FR2980702A1/en
Application granted granted Critical
Publication of FR2980702B1 publication Critical patent/FR2980702B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)

Abstract

Composition comprises substituted iridoid compounds (I) and/or substituted furanol compounds (II), or their plant extracts, and at least one nucleophilic compounds (a)-(h) optionally comprising an anion or its mixture to ensure electrical neutrality of the composition, and polyallylimidazolium oligomers or polymers. Composition comprises substituted iridoid compounds of formula (I) and/or substituted furanol compounds of formula (II) and their optical and geometrical isomers, inorganic or organic acid salts or solvates, or their plant extracts, and at least one nucleophilic compounds of formula (a)-(h) or its optical or geometrical isomer, organic or mineral acid salt or solvate, where the nucleophilic compounds optionally comprise an anion or its mixture to ensure electrical neutrality of the composition, and polyallylimidazolium oligomers or polymers. R1 : H, CH 3, hydroxymethyl, aldehyde, -CO 2R4 or -CH 2-glucose; R4 : H or 1-2C alkyl; R2 : H, hydroxy or glucose radical; R3 : H, hydroxy or 1-4C-alkyloxy, where the number of hydroxy groups is = 2; R5, R6 : H or -CO 2R6a; R6a : H, 1-2C alkyl, metal alkali cation or ammonium groups; n, n1 : 0-4; n2 : 0-2, where the unsubstituted carbon atoms bear a hydrogen atom; A : -CR-10-, -N- or -N +>R11; R11 : 1-4C alkyl; X : N or CR7a; R7a : H or R7; either R7 : 1-4C alkyl, OH, 1-4C alkoxy, amino or 1-4C alkylamino; or R7+R7 : 5- or 6-membered heterocycle comprising 1 or 2 heteroatoms containing O and/or N; either R8, R10 : 1-4C alkyl (optionally substituted with at least one group of -COOR12 or -OCOR12), H, OH, amino, -COR13, -COOR14, -OCOR14 or -OSO 3 ->; and R9 : H, 1-4C alkyl, 1-4C alkylcarbonyl or acetyl; or R8R9 : 5- or 6-membered heterocycle optionally comprising another heteroatom containing O, N or S, where the heterocycle is optionally interrupted with CO group; R12, R13 : 1-4C alkyl; R14 : H or 1-4C alkyl (optionally substituted with at least one 1-4C alkoxy); A1 : S, -(CR18) 2- or -C(R19)=C(R19a)-; R18 : H or 1-4C alkyl; B1 : S; R19, R19a : H or 1-4C alkyl; R15 : 1-4C alkyl, halo, preferably Cl, or 1-4C alkoxy; R15a : 1-2C alkyl; either R16 : H or 1-4C alkyl; and R17 : 1-4C alkyl optionally bearing a hydroxyl group; or R16R17 : 5- or 6-membered fused heterocycle optionally containing one or more unsaturations (optionally substituted with at least one 1-4C alkyl radical); R16a : H or 1-4C alkyl; R17a : H or 1-4C alkyl, where the alkyl group is optionally bearing a hydroxyl or phenyl radical and optionally interrupted with a CO group; R20 : 1-4C alkyl, halo (preferably Cl, Br or I), -COOR21 or -OCOR21; R21 : H, 1-4C alkyl, amino or 6C aryl (optionally substituted with at least one hydroxyl radical); X : N, -CR22 or -CR22a-CO-, where CR22a is linked to Y1 or X; Y1 : N or -CR22aa; either R22, R22a, R22aa : H or linear or branched 1-4C alkyl (optionally substituted with amino, benzyl, phenyl, -COOR23 or -OCOR23); R23 : 1-4C alkyl or -SOR24; or R22, R22aa : fused 6-membered aryl ring; R24 : 1-4C alkyl; Y2 : CH, CR27 or N; Z : N; Z1 : N or NR27a; q : 0-3; r, s : 1 or 2; t : 0-4; u : 0 or 1, where the unsubstituted carbon atoms of the heterocycles contain a hydrogen atom; R27 : linear 1-4C alkyl, halo, preferably Cl, Br or F; R28 : H or linear 1-4C alkyl radical, where the radicals R27 located ortho to the radical NHR28 and R28 is together to form a 5- or 6-membered heterocycle comprising 1 or 2 heteroatoms of O or N; R29 : linear 1-4C alkyl, where the two radicals R29 together optionally forming a saturated 5-membered heterocycle; either R27a : H, 1-4C alkyl or phenyl radicals; and R31 : 1-4C alkyl, 1-4C alkoxy (optionally substituted with OH) or amino (optionally substituted with -COCH 3); or R27aR31 : 5- or 6-membered (non)aromatic heterocycle (optionally substituted with 1-4C alkyl); or R31R31 : aromatic ring (optionally substituted with an amino radical); and R30 : OH, amino or pyrrolidyl group. Provided that: when A is N, n is 0, X is CH and R8 is NH 2, then R9 is not H or CH 3; if Y2 is CR27, then q is preferably other than 0; and at least one of the radicals R31 is other than hydrogen and/or at least u is 1. Independent claims are included for: (1) coloring human keratin fibers, preferably hair comprising applying the composition on the fibers; and (2) a multicompartment device comprising a first compartment containing (I) or their plant extracts, and a second compartment containing (a)-(h), nucleophilic oligomers or polymers. [Image] [Image].
FR1158748A 2011-09-29 2011-09-29 COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE Expired - Fee Related FR2980702B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1158748A FR2980702B1 (en) 2011-09-29 2011-09-29 COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE
PCT/EP2012/069362 WO2013045702A2 (en) 2011-09-29 2012-10-01 Dye composition comprising a non-glycosyl iridoid compound and a specific nucleophile or an amino or thio polymer, dyeing process, and device therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1158748A FR2980702B1 (en) 2011-09-29 2011-09-29 COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE

Publications (2)

Publication Number Publication Date
FR2980702A1 FR2980702A1 (en) 2013-04-05
FR2980702B1 true FR2980702B1 (en) 2013-09-13

Family

ID=45524689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1158748A Expired - Fee Related FR2980702B1 (en) 2011-09-29 2011-09-29 COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE

Country Status (1)

Country Link
FR (1) FR2980702B1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660089B2 (en) * 1990-01-23 1994-08-10 六郎 清原 Hair dye cosmetics
JP2842915B2 (en) * 1990-02-02 1999-01-06 株式会社トキワ漢方製薬 Hair dyes and hair cosmetics
JPH05339134A (en) * 1992-06-05 1993-12-21 Kii Kasei Kk Hair dye
FR2699816B1 (en) * 1992-12-30 1995-03-03 Oreal Dyeing compositions for keratin fibers based on paraphenylenediamines, metaphenylenediamines and benzimidazole derivatives, and dyeing process using them.
US7635394B2 (en) * 2005-11-09 2009-12-22 L'oreal S.A. Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives
TWI386229B (en) * 2006-06-07 2013-02-21 Kao Corp One-part hair dye composition
FR2902327B1 (en) * 2006-06-20 2008-08-08 Oreal KERATIN FIBER COLORING COMPOSITION COMPRISING 2,3-DIAMINO-6,7-DIHYDRO-1H, 5H-PYRAZOLO-1,2-A PYRAZOL-1-ONE, PARA-PHENYLENEDIAMINE OR PARA-TOLUENEDIAMINE AND META-AMINOPHENOL SUBSTITUTES
US20100120871A1 (en) * 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair

Also Published As

Publication number Publication date
FR2980702A1 (en) 2013-04-05

Similar Documents

Publication Publication Date Title
PE20161371A1 (en) ORGANIC MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
DE69100079D1 (en) NAPHTHALINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
IN2014DN03063A (en)
JPS5746986A (en) Pyrido(1,2,3-de)(1,4)benzoxazine derivative
FR2921381B1 (en) HEMICYANINE STYRYLE THIOL / DISULFIDE DYE, TINCTORIAL COMPOSITION COMPRISING THE DYE, METHOD OF CLEANING KERATINIC MATERIALS FROM THAT COLORANT
BRPI0602122A (en) keratin fiber staining composition, keratin fiber staining process, device and use of a composition
BR0316690A (en) Compound, prodrug, method for producing an antibacterial effect on a warm-blooded animal, use of a compound, pharmaceutical composition, and process for preparing a compound
MX9703634A (en) Antibacterial dibenzimidazole derivatives.
FR2980702B1 (en) COLORING COMPOSITION COMPRISING NON-GLYCOSYL IRIDOID COMPOUND AND PARTICULAR NUCLEOPHILIC, COLORING PROCESS, AND DIPOSITIVE
SE8301929D0 (en) NEW CARBAPEN NAME DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND NEW INTERMEDIATES FOR USE IN THESE PROCEDURES
ATE130299T1 (en) CEPHALOSPORIN COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME.
AU553693B2 (en) Benzodioxine derivatives
FI955386A (en) 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromene-4-one derivatives, their preparation and their use in the management of psychosis and schizophrenia
FI952203A (en) Cyclohexane derivatives, process for their preparation and use of the compounds for the treatment of diseases
BG100551A (en) 2-(pyrazol-3-yl)carbapenem derivatives
DE3669714D1 (en) CHINOLON INOTROPICAL AGENTS.
ES518490A0 (en) A PROCEDURE FOR THE PREPARATION OF CERTAIN CARBONATES OF 6- (2-AMINO-2-PHENYL-ACETAMIDE-PENICILANOYLOXIMETIL) -1,1-DIOXOPENICILANOILOXIMETILO AS ANTIBACTERIAL AGENTS.
CA2381243A1 (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AR078818A1 (en) DERIVATIVES OF AZAINDOL
CS9100765A2 (en) Trifluormethylmercaptan and mercaptoacylic derivatives and method of their preparation and application
ATE147376T1 (en) HETEROCYCLIC DERIVATIVES
BR112016026074B1 (en) METHODS FOR FORMING COMPOUNDS
SE7905520L (en) cephalosporin derivatives
FR2405234A1 (en) Antilipaemic tri:fluoromethyl substd. aryl-alkanoic acid derivs. - used for treating hyperlipaemia, hypercholesterolaemia and atheroma
AR031844A1 (en) ENZYMATIC RESOLUTION OF SELECTIVE MODULATORS OF STROGEN RECEIVERS

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160531